Symptom Control in the Last 48hrs

Slides:



Advertisements
Similar presentations
Anticipatory prescribing
Advertisements

Syringe Driver Drugs.
LIFE-LIMITING ILLNESS
Preparing for the Predictable Planning for common threats to comfort in the final days. Tamara Wells RN MN CNS Dr. M. Harlos Medical Director WRHA Palliative.
Palliative Care Dr Rachel Dawson. Objectives Increase your confidence in dealing with palliative care cases.
Pancreatitis Acute pancreatitis. Definition Is an inflamation of the pancreas ranging from mild edema to extensive hemorrhage the structure and function.
DYSPEPSIA Dr.Vishal Rathore. Dyspepsia popularly known as indigestion meaning hard or difficult digestion, is a medical condition characterized by chronic.
IMAGE CHALLENGE. A 51-year-old woman with a history of hypertension and chronic constipation presented with abdominal pain of 2 weeks' duration. The.
The Last Days - the Essentials Dr Mary Kiely Consultant in Palliative Medicine CHfT.
Bowel Symptoms 1: Nausea & Vomiting Dr Iain Lawrie.
Management of Nausea & Vomiting
SYRINGE DRIVERS Coranne Rice.
UNDERSTANDING BREATHLESSNESS IN 10’ish MINUTES! Dr David Plume Macmillan GP Facilitator, Central Norfolk.
{ Management of Advanced Breathlessness Dr Phil Wilkins, Norfolk and Norwich University Hospital and Priscilla Bacon Lodge, Norwich.
Pain Assessment and Management
PROBLEM BASED LEARNING
UNDERSTANDING BREATHLESSNESS IN 10’ish MINUTES!
P ALLIATIVE C ARE By Hannah Wright GPST1 Teaching 17 th April 2013.
Safe discharge from hospital?
End of Life Care Education Case Scenario 3 End of Life Care Webinar MODULE 1.
Post Liverpool Care Pathway End of Life Conference Wednesday 14 May 2014 Dr Catherine J Dent Associate Specialist Macmillan Specialist Palliative Care.
Managing Symptoms in Palliative Care. Aims  To gain an awareness of the most common symptoms in patients with life limiting diseases and why these occur.
End of Life Symptom Management Dec 3, 2014 Mudit Dabral Rosene Pirrello.
NYU Medicine Grand Rounds Clinical Vignette Himali Weerahandi, PGY3 March 6, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Dignity and Symptom Control Rachel Sheils GSFCH Conference
By Dr Marie Joseph MB BS FRCP Medical Director & Consultant in Palliative Medicine St Raphael’s Hospice, Surrey and Macmillan Consultant, Epsom & St Helier.
Bradford & Airedale Palliative Care Managed Clinical Network Last few days of life Symptom Control.
Jacquie Upton Hospice at Home Lead
Side effects and toxicity of analgesics Disclaimer: This presentation contains information on the general principles of pain management. This presentation.
5 mins on last days of life and palliative care emergencies ! Dr. Ros Taylor Hospice Director Hospice of St. Francis Berkhamsted June 2012.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
Pain control and controlled drug prescribing Gayle Munro Specialist Pharmacist
Foundation Teaching Wendy Caddye Senior CNS Acute Pain.
Innovation and excellence in health and care Addenbrooke’s Hospital I Rosie Hospital FY1 Introduction to Palliative Care 7 th August 2015 Clinical Nurse.
Top Tips in Palliative Care Dr Claire Curtis (in collaboration with the Worcestershire Specialist Palliative Care Teams) Nov 2012 Click to continue.
Click to continue. Convulsions Most self limiting – only need supportive care – Reassure carer, advise contacting DN for support Rectal diazepam 10mg.
Care at the end of life in hospital Dr David Oliver Consultant Physician Wisdom Hospice Honorary Reader University of Kent
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Step 5 workshop. Step 5 - Plan Recognising when an individual enters the dying phase Appropriate and inappropriate hospital admissions at end of life.
Scenario 1 Patient is entering terminal phase MST 120mg bd sevredol 40mg if required metoclopramide 10mg tds diclofenac 50mg tds contact: unable to take.
Management: Spinal Cord Compression
End of Life Care in MND Dr Sarah Forrest.
Palliative Management of Heart Failure
Bone Pain: A Practical Approach to Management
Delirium in the Last Hours and Days of Life (updated) Dr Dan Monnery
Section II: Frequent Symptoms Associated with Imminent Death
Managementn of RespiratorySymptoms in Cancer Patients
Pain and Symptom Management
The Terminal Phase Rob Woodford ST1.
Palliative Care in the Outpatient Setting: Pain Management
Dr Alison Giles Palliative Medicine Consultant
Hospice in Hospital - GIP and Beyond
Tania's JOURNEY.
Oncology Outreach/Specialist Palliative Care Team
Dr Helen Morrison Beatson West of Scotland Cancer Centre
Opioids and other drugs we use in palliative care
Cancer Pain David Cameron
Sedation and Anagesia in Critical Care
PALLIATIVE MEDICINE NAUSEA, VOMITING, BOWEL OBSTRUCTION
Dr Sarah Callin Consultant in palliative Medicine
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Cholelithiasis Pathophysiology Pigment stones Cholesterol stones
Nausea & Vomiting ‘made easy’.
Palliative care for end stage respiratory disease
How do I manage pain and agitation?
Death, Dying, and the Grieving Process
Nausea & Vomiting in Cancer Patients
Nausea and vomiting in Cancer Patients
Pain Management in Palliative Care
Palliative and End of Life Care for patients with Dementia
Presentation transcript:

Symptom Control in the Last 48hrs Dr Bisharat El Khoury Consultant in Palliative Medicine NUH

Objectives Recognise patient is dying Planning end of life care-MDT Symptom management Psychological and emotional support Patient and family/ carers Each other

How do you recognise a patient is dying?

Recognising Death Profoundly weak Bed bound Very limited oral intake Drowsy/ semi-comatose Confused/ agitated Unable to swallow medication

Planning End of Life Care Wishes of family/ coping at home Planning for crisis – Anticipatory Prescribing Drug administration and prns Discuss 999/ resuscitation DNACPR

Main Aims of Treatment STOP unnecessary drugs STOP unnecessary intervention i.e. BP, pulse Manage symptoms Psychological support Patient Carers/ family Yourself

Management Continue to assess bladder, bowels

Indications for Using a Syringe Driver Essential meds if unable to take oral Semi-comatose Vomiting, swallowing difficulties Confused/ agitated

Symptoms Pain Nausea & Vomiting Terminal agitation Breathlessness Death rattle Haemorrhage

Pain Assess cause i.e. urinary retention Route of medication Ensure breakthrough analgesia available

Pain – If Not On Opioids Provide prn morphine 2.5-5mg sc up to 1hrly if needed Review after 24hrs – if 2+ doses start syringe driver

Pain-if On Opioids Convert 24hr PO morphine to 24hr CSCI morphine – divide by 2 Convert 24hr PO morphine to 24hr CSCI diamorphine – divide by 3 Convert 24hr PO oxynorm to 24hr CSCI oxycodone – divide by 2 Continue to give prn pain relief if needed (1/6 of total)

Pain Do not start Fentanyl patches Provide prn analgesia

Fentanyl and Equivalent Doses Compared to Oral Morphine 1:100 Fentanyl patches mcg/72hrs Morphine po Mg/24hrs 12 30 25 60 50 120 75 180 100 240

Fentanyl Patches in the Terminal Phase Leave patch on, continue to change every 72hrs Give doses of sub cut morphine for breakthrough pain If 2+ prns needed/ 24hrs give morphine by CSCI starting with sum of prn doses in last 24hrs

Renal Impairment e GFR < 30ml/min Stage 4/5 Chronic Kidney Disease There is no exact equivalence between opioids

Anticipatory Medication Renal Impairment - Pain Use smaller doses of opioids the patient is on ie 1/2mg oxycodone/ morphine po/sc Better to be familiar with the opioid Opioids of choice are Alfentanil and Fentanyl

Renal Impairment – Pain if not on regular opioid Alfentanil 100micrograms or Fentanyl 25micrograms prn If needing prns consider syringe driver with Alfentanil 500mcg or Fentanyl 100mcg

Alfentanil 1mg Alfentanil subcut is equivalent to 30mg oral morphine Hepatic metabolism inactive metabolites excreted in urine Rapid onset of action and used in procedure related pain Ensure prn dose

Fentanyl 1mg Fentanyl is equivalent to 150mg oral morphine Can use trans mucosal Fentanyl products earlier Fentanyl patch continue and use prns Ensure prn doses available

A 51-year-old woman with a history of hypertension and chronic constipation presented with abdominal pain of 2 weeks' duration A 51-year-old woman with a history of hypertension and chronic constipation presented with abdominal pain of 2 weeks' duration. The pain was continuous, worsened with eating, was associated with nausea, and radiated to her back. She reported no vomiting, fever, diarrhea, or weight loss, and her vital signs were normal. Her abdomen was distended, diffusely tender on palpation, and tympanic on percussion on the upper half and dull on the lower half. Bowel sounds were missing on the left side, and a large mass was palpated in that area. Laboratory evaluation was unremarkable. Computed tomography (CT) showed massive dilatation of the stomach, and gas was seen distally on a CT scan. More than 4 liters of fluid was drained from the patient's stomach during the first 24 hours. Upper gastrointestinal endoscopy showed no evidence of peptic ulcer disease or cancer but did show hypertrophic pyloric stenosis. She underwent endoscopic balloon dilation of the pyloric sphincter, with immediate symptomatic relief and resolution of gastric dilatation. Within a few days, the patient returned to a normal diet, and 20 months later, she continued to do well.

Nausea & Vomiting Nausea - unpleasant feeling of need to vomit, often with autonomic symptoms Retching - rhythmic laboured movements of diaphragm and abdominal muscles Vomiting- forceful expulsion of gastric contents

Common causes of N&V - cancer

Correct The Correctable Cough - antitussive Gastritis - antacid Gastric irritant drugs - ie NSAID ? Stop Constipation - laxative Raised ICP - corticosteroid Hypercalcaemia - zometa

N & V End of Life If cause known and previous antiemetics working Continue and give parenterally

N & V End of Life If cause unknown or unrelieved by previous antiemetics Use levomepromazine broad spectrum Start 6.25-12.5mg po/sc o.n. and prn Can be given prn up to 1 hourly if needed If 2+ doses use CSCI

Nausea & Vomiting Give regularly and reassess Treat cause ie renal failure reduce opioids Consider CSCI – can be used for anti-emetic alone Seek advice

Terminal Agitation Change in behaviour Reduced awareness Mental distress/ anguish Fluctuating confusion Hallucinations/ paranoid ideas

Terminal Agitation Associated with progressive multi-organ failure Generally not reversible Medication usually necessary 85% patients prior to death

Causes of Terminal Agitation Psychological Fear Unfinished business Biochemical Liver/ renal failure Raised calcium Hypoxia Physical Pain Full bladder Full rectum Hypoxia/ breathlessness Cerebral metastases

Management of Terminal Agitation Treat cause General measures Nursing the patient-reassure, environment, safety Carers-explanation Review drugs/ reduce medication Treat symptom Midazolam (high doses can sometimes worsen if used alone) Levemepromazine

Drugs Commonly Used Midazolam Levomepromazine Haloperidol

Drug Treatment Antipsychotics are the drug of choice BZD if given alone can make agitation worse

Levomepromazine Phenothiazine antipsychotic, anti-emetic Half life 16-30hrs Analgesic properties Sedating

Levomepromazine Highly anxious pts who are overwhelmed Pain exacerbated with onset of delirium

Levomepromazine Typical breakthrough sc doses 6.25-12.5mg to 12.5-25mg Syringe driver start 12.5-25mg/24hrs Maximum dose 300mg/24hrs

Midazolam BZD Half life 2-5hrs Reduces neuronal activity Single stat dose 2-3x more potent than diazepam

Midazolam CSCI 10-30mg to 30-60mg/24hrs Start 20-30mg/24hrs if fitting/ on antiepileptics Breakthrough doses 2.5-5mg to 5-10mg can be give hrly and with antipsychotic

Midazolam Can make agitation worse if used alone If needing higher doses use an antipsychotic

Breathlessness Subjective difficulty in breathing associated with high levels of anxiety and fear (different from tachypnoea and hyperventilation) OHPC 2005

Breathlessness Explanation/ relaxation Repositioning Fan If O2 sat< 90% use oxygen 2-4l/min

Breathlessness Common in palliative care 40-80% Complicated pathopysiology Do not assume it is caused by cancer If due to cancer ? treat cancer Look for reversible causes

Reversible causes ? Bronchopneumonia Anaemia Pleural effusion COPD PE SVCO Heart failure

                   

Patients Experience Common trigger for panic Intermittent – exertion, bending, talking Restriction of ADL/ social life Feelings anxiety, pain, impending death

Terminal Breathlessness Explanation to family/ carers Use opioid with sedative- anxiolytic CSCI Diamorphine/ morphine + midazolam If agitated add levomepromazine/ haloperidol

Drug Treatment -Opioids Reduce ventilatory response so reducing respiratory effort and SOB Also reduce tidal volume and RR Generally more beneficial for pts SOB at rest

Opioid Naive Start low 2.5-5mg sc/po morphine Titrate to response and effect If 2+ doses in 24hrs prescribe regularly Always provide prns

Patients on opioids Use PRN dose – may need less or more Some patients may tolerate CSCI with morphine/ diamorphine better

Anxiolytics To reduce panic/ anxiety – use prn also Diazepam 1-2mg po Lorazepam 0.5-1mg sl/po Midazolam 2.5-5mg stat Midazolam 5-10mg/ 24hrs CSCI

Respiratory Symptoms Severe acute stridor Bleed into bronchus or trachea Noisy tachypnoea

Oxygen Use if hypoxic Decreases work of breathing Consider fan/ open window

Death Rattle Secretions in hypopharynx-oscillation If patient not distressed treatment for carers/staff Explanation important

Death Rattle Support-explanation Postural drainage Suction

Death Rattle Main treatment Buscopan/ Hyoscine butylbromide Give promptly-no effect on existing secretions Maximum dose 300mg/24hrs

Death Rattle Stat dose buscopan 20mg sc up to hrly If 2+doses in 24hrs start CSCI 40-80mg buscopan/ 24hrs Continue to give prns if needed

Catastrophic Bleed Stay with patient Prepare-green/ red towels Occasionally medication

Psychological Support How long? Loss control-explanation Fear-feeling safe/ valued Spirituality

Psychological Support Prepare-drugs, catheter, driver etc Recognising own emotions/ support each other

Bereavement Follow up support Risk factors Discussion/ learning/ audit

Case Study 87yr woman lung ca dying at home, supportive family, symptoms well controlled Current meds: oramorph 5mg tds, paracetamol, cyclizine 50mg tds

Swallowing becomes difficult – what do you suggest?

Prepare family CSCI diamorphine 5mg, cyclizine 150mg/24hrs

The next day she becomes unsettled and c/o abdominal pain – what could be happening?

Urinary retention – the pain and agitation settle on catheterisation

Later she becomes agitated and verbally aggressive Later she becomes agitated and verbally aggressive. The family admit this has been happening for short periods over the last few days.

Case Study Explanation Unable to get medication she is admitted to QMC and dies the next day CSCI diamorphine 5mg, levomepromazine 12.5mg, midazolam 10mg/24hrs

Contacts Hayward House 0115 969 1169 and ask switchboard to ring palliative care doctor on call Direct line 0115 962 7619